AZD8421
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD8421, covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]